Related Experiment Video
Updated: Jan 21, 2026

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
Published on: November 14, 2016
Differential Diagnostics of Active Progressing Multiple Sclerosis Using a Fluorescent Biomarker with Resonance Energy
Ya A Lomakin1,2, A A Kudryaeva1, N N Kostin1
1M. M. Schemyakin and Yu. A. Ovchinnnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.
Researchers developed a new multiple sclerosis (MS) biomarker using a fluorescent protein substrate. This substrate is degraded by autoantibodies from MS patients, showing promise for MS diagnostics.
Area of Science:
- Neuroimmunology
- Biochemistry
- Biomarker Development
Background:
- Autoantibodies targeting myelin basic protein (MBP) are implicated in multiple sclerosis (MS).
- Previous biomarkers utilized antibody-mediated cleavage of MBP fragments, but a next-generation approach is needed.
Purpose of the Study:
- To develop an advanced, antibody-dependent biomarker for multiple sclerosis (MS).
- To create a novel fluorescent substrate for detecting MS-specific autoantibody activity.
Main Methods:
- Chemically synthesized a fluorescent resonance energy transfer (FRET) substrate (Cy5-MBP81-99-QXL680).
- Incubated the substrate with purified antibodies and B cells from MS patients and healthy volunteers.
Main Results:
- The novel FRET substrate demonstrated degradation in the presence of antibodies and B cells from multiple sclerosis patients.
- No significant degradation was observed with samples from healthy volunteers, indicating specificity.
Conclusions:
- The developed FRET substrate serves as a sensitive and specific biomarker for multiple sclerosis.
- This next-generation biomarker shows potential for improved MS diagnostics and understanding of disease mechanisms.
Related Concept Videos
Activation Energy
Resonance
Energy Transfer in Chemical Reactions
Bond Dissociation Energy and Activation Energy
Enzymes and Activation Energy
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...

